Mesenteric artery calcium scoring: a potential screening method for chronic mesenteric ischemia.

Chronic mesenteric ischemia lacks a widely accepted screening method. Current diagnostic approaches often rely on clinical symptoms and invasive testing. While computed tomography angiography is commonly used, it may not always provide clear diagnostic guidance. Prior research has shown that atherosclerosis is a known contributor to mesenteric ischemia. However, no standardized calcium scoring system exists for mesenteric arteries. This gap motivated the development of a mesenteric artery calcium score (MACS) as a potential screening metric. That uncertainty drove the need to evaluate MACS as a diagnostic tool. No prior work had resolved the feasibility of calcium scoring in mesenteric arteries. This study aimed to address that gap by testing MACS in a clinical setting.

The study aimed to assess whether mesenteric artery calcium scoring could serve as a practical screening method for chronic mesenteric ischemia. Researchers focused on evaluating the diagnostic potential of MACS in distinguishing CMI from non-CMI patients. They sought to determine if calcium scoring could reduce diagnostic delays and improve early recognition of the condition. The motivation stemmed from the high risk of undertreatment in CMI due to diagnostic challenges. The study also aimed to assess interobserver agreement in MACS scoring. Additionally, the researchers wanted to evaluate how scan and reconstruction parameters affect MACS results. They proposed that MACS could complement existing diagnostic tools. This approach could help streamline patient triage in clinical practice.

The study used a retrospective design with CT angiography scans from patients suspected of CMI. A custom software module was developed to calculate MACS using the Agatston calcium scoring method. Scans of the celiac artery, superior mesenteric artery, and inferior mesenteric artery were analyzed. Two blinded observers independently scored the MACS in 39 cases to assess interobserver agreement. CMI was defined as symptom improvement following treatment, while non-CMI patients showed no improvement. The study included 184 patients, with 49 diagnosed with CMI and 135 classified as non-CMI. ROC analysis was used to evaluate MACS diagnostic performance. The impact of scan and reconstruction parameters was tested in 29 patients with repeated CTAs.

The MACS was successfully obtained in 184 patients, with CMI patients showing significantly higher scores than non-CMI patients. Interobserver agreement was excellent, with an intraclass correlation coefficient of 0.910. The combined MACS of the celiac artery and superior mesenteric artery showed an AUC of 0.767 in ROC analysis. At a cutoff of ≥29.7, the MACS demonstrated high sensitivity (87.8%) and high negative predictive value (92.1%). The study found that scan and reconstruction parameters significantly affected MACS values. A comparison of two CTAs in 29 patients revealed variability in MACS due to these parameters. These findings suggest MACS could serve as a screening tool for CMI. However, correction for imaging parameters is necessary to ensure accurate results.

The authors propose that mesenteric artery calcium scoring may serve as a promising screening method for chronic mesenteric ischemia. They suggest that MACS could help identify patients who may benefit from further diagnostic evaluation. The high negative predictive value of MACS could aid in ruling out CMI in non-CMI patients. The excellent interobserver agreement supports the reliability of MACS as a diagnostic tool. The study also highlights the need to account for scan and reconstruction parameters when calculating MACS. The authors emphasize that further development is required to standardize MACS calculations. They suggest that MACS could complement existing diagnostic approaches in clinical practice. These findings may contribute to improving early detection and management of CMI.